Salivary cytokine profile in patients with ischemic stroke

Abstract Inflammation plays a crucial role in stroke pathogenesis. Thus, it is not surprising that cytokines, chemokines, and growth factors have been advocated in stroke diagnostics. Our study is the first to evaluate the salivary cytokine profile in patients with ischemic stroke. Twenty-five patie...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mateusz Maciejczyk, Kacper Maksymilian Mil, Piotr Gerreth, Katarzyna Hojan, Anna Zalewska, Karolina Gerreth
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5016893d3611498a92c46cc4fd418b14
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5016893d3611498a92c46cc4fd418b14
record_format dspace
spelling oai:doaj.org-article:5016893d3611498a92c46cc4fd418b142021-12-02T15:09:15ZSalivary cytokine profile in patients with ischemic stroke10.1038/s41598-021-96739-02045-2322https://doaj.org/article/5016893d3611498a92c46cc4fd418b142021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-96739-0https://doaj.org/toc/2045-2322Abstract Inflammation plays a crucial role in stroke pathogenesis. Thus, it is not surprising that cytokines, chemokines, and growth factors have been advocated in stroke diagnostics. Our study is the first to evaluate the salivary cytokine profile in patients with ischemic stroke. Twenty-five patients with subacute ischemic stroke and an age-, sex-, and oral hygiene status-matched control group were enrolled in the study. The number of patients was set a priori based on our previous experiment (α = 0.05, test power = 0.9). Salivary concentrations of tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), and interleukin 10 (IL-10) were assessed using an ELISA method. We showed that salivary TNF-α and IL-6 were significantly higher, whereas IL-10 content was statistically lower in both non-stimulated (NWS) and stimulated (SWS) whole saliva of ischemic stroke patients. However, evaluation of cytokines in NWS rather than in SWS may be of greater diagnostic value. Of particular note is salivary TNF-α, which may indicate cognitive/physical impairment in post-stroke individuals. This parameter distinguishes stroke patients from healthy controls and correlates with cognitive decline and severity of functional impairment. It also differentiates (with high sensitivity and specificity) stroke patients with normal cognition from mild to moderate cognitive impairment. Saliva may be an alternative to blood for assessing cytokines in stroke patients, although further studies on a larger patient population are needed.Mateusz MaciejczykKacper Maksymilian MilPiotr GerrethKatarzyna HojanAnna ZalewskaKarolina GerrethNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Mateusz Maciejczyk
Kacper Maksymilian Mil
Piotr Gerreth
Katarzyna Hojan
Anna Zalewska
Karolina Gerreth
Salivary cytokine profile in patients with ischemic stroke
description Abstract Inflammation plays a crucial role in stroke pathogenesis. Thus, it is not surprising that cytokines, chemokines, and growth factors have been advocated in stroke diagnostics. Our study is the first to evaluate the salivary cytokine profile in patients with ischemic stroke. Twenty-five patients with subacute ischemic stroke and an age-, sex-, and oral hygiene status-matched control group were enrolled in the study. The number of patients was set a priori based on our previous experiment (α = 0.05, test power = 0.9). Salivary concentrations of tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), and interleukin 10 (IL-10) were assessed using an ELISA method. We showed that salivary TNF-α and IL-6 were significantly higher, whereas IL-10 content was statistically lower in both non-stimulated (NWS) and stimulated (SWS) whole saliva of ischemic stroke patients. However, evaluation of cytokines in NWS rather than in SWS may be of greater diagnostic value. Of particular note is salivary TNF-α, which may indicate cognitive/physical impairment in post-stroke individuals. This parameter distinguishes stroke patients from healthy controls and correlates with cognitive decline and severity of functional impairment. It also differentiates (with high sensitivity and specificity) stroke patients with normal cognition from mild to moderate cognitive impairment. Saliva may be an alternative to blood for assessing cytokines in stroke patients, although further studies on a larger patient population are needed.
format article
author Mateusz Maciejczyk
Kacper Maksymilian Mil
Piotr Gerreth
Katarzyna Hojan
Anna Zalewska
Karolina Gerreth
author_facet Mateusz Maciejczyk
Kacper Maksymilian Mil
Piotr Gerreth
Katarzyna Hojan
Anna Zalewska
Karolina Gerreth
author_sort Mateusz Maciejczyk
title Salivary cytokine profile in patients with ischemic stroke
title_short Salivary cytokine profile in patients with ischemic stroke
title_full Salivary cytokine profile in patients with ischemic stroke
title_fullStr Salivary cytokine profile in patients with ischemic stroke
title_full_unstemmed Salivary cytokine profile in patients with ischemic stroke
title_sort salivary cytokine profile in patients with ischemic stroke
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/5016893d3611498a92c46cc4fd418b14
work_keys_str_mv AT mateuszmaciejczyk salivarycytokineprofileinpatientswithischemicstroke
AT kacpermaksymilianmil salivarycytokineprofileinpatientswithischemicstroke
AT piotrgerreth salivarycytokineprofileinpatientswithischemicstroke
AT katarzynahojan salivarycytokineprofileinpatientswithischemicstroke
AT annazalewska salivarycytokineprofileinpatientswithischemicstroke
AT karolinagerreth salivarycytokineprofileinpatientswithischemicstroke
_version_ 1718387872842645504